Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?

J Hepatol. 2002 Mar;36(3):445-6. doi: 10.1016/s0168-8278(01)00283-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Resistance, Microbial
  • Hepatitis B / drug therapy*
  • Hepatitis B / virology
  • Hepatitis B virus / drug effects*
  • Humans
  • Lamivudine / therapeutic use*
  • Predictive Value of Tests
  • Reverse Transcriptase Inhibitors / therapeutic use*

Substances

  • Reverse Transcriptase Inhibitors
  • Lamivudine